2000 (Cycle VI)
Innovative Awards: IDEA (Innovative, Developmental, and Exploratory Awards) Top
| Mammography Density and Sex Steroid Genes | ||||
| University of Southern California | ||||
| Research Priority: Etiology > Hormones & nutrition | ||||
| Award Type: IDEA | ||||
| DNA Polymorphisms and Breast Cancer in a Multi-ethnic Cohort | ||||
| University of Southern California | ||||
| Research Priority: Etiology > Environment & gene/environment interactions | ||||
| Award Type: IDEA | ||||
| Race/Ethnicity, Socioeconomic Status and Breast Cancer | ||||
| Public Health Institute | ||||
| Research Priority: Health Policy & Health Services > Health Policy & Health Services | ||||
| Award Type: IDEA | ||||
| Arginine Deiminase as an Innovative Anti-Breast Cancer Agent | ||||
| University of Southern California | ||||
| Research Priority: Innovative Treatments > New drug design | ||||
| Award Type: IDEA | ||||
| A Novel Antigen Associated with Breast Cancer Metastasis | ||||
| Sidney Kimmel Cancer Center | ||||
| Research Priority: Pathogenesis > Searching the unknown | ||||
| Award Type: IDEA | ||||
Collaboration Awards: Joining Forces Conference Awards Top
| Cancer and Complexity: Questions for a New Millenium | ||||
| Lawrence Berkeley National Laboratory | ||||
| Research Priority: Biology of the Normal Breast > Breast function | ||||
| Award Type: Joining Forces | ||||
Collaboration Awards: SPRC (Scientific Perspectives Research Collaboration) Exploratory Awards Top
| Computer-Aided Discovery of Novel Breast Cancer Therapeutics | ||||
| Molecular Research Institute | ||||
| Research Priority: Innovative Treatments > New drug design | ||||
| Award Type: SPRC Exploratory | ||||
Collaboration Awards: TRC (Translational Research Collaboration) Pilot Awards Top
| Physical Activity and Diet in Adolescents with Disabilities | ||||
| California State University, Northridge | ||||
| Research Priority: Etiology > Hormones & nutrition | ||||
| Award Type: TRC Pilot | ||||
Career Development Awards: Postdoctoral Fellowship Top
| Genes Determining Estrogen Susceptibility in Breast Cancer | ||||
| Stanford University | ||||
| Research Priority: Etiology > Hormones & nutrition | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Tamoxifen-Induced Endometrial Cell Transformation | ||||
| Salk Institute for Biological Studies | ||||
| Research Priority: Etiology > Hormones & nutrition | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Role of MMPs in Breast Tumor Initiation and Aggressiveness | ||||
| Lawrence Berkeley National Laboratory | ||||
| Research Priority: Pathogenesis > Outbreak - how cancer spreads | ||||
| Award Type: Postdoctoral Fellowship | ||||
| The Role of N-CoR During Normal Mammary Gland Development | ||||
| University of California, San Diego | ||||
| Research Priority: Biology of the Normal Breast > Breast development | ||||
| Award Type: Postdoctoral Fellowship | ||||
| A New Class of Drugs to Treat Breast Cancer | ||||
| University of California, San Francisco | ||||
| Research Priority: Innovative Treatments > Hormone and chemotherapy targets | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Anti-E-Cadherin Apoptosis of Inflammatory Breast Carcinoma | ||||
| University of California, Los Angeles | ||||
| Research Priority: Pathogenesis > Cell growth | ||||
| Award Type: Postdoctoral Fellowship | ||||
| A Novel Signal Transduction Pathway in Breast Cancer | ||||
| University of California, San Diego | ||||
| Research Priority: Pathogenesis > Cell growth | ||||
| Award Type: Postdoctoral Fellowship | ||||
| The Role of the BMK1-MEKK3 Pathway in Breast Cancer | ||||
| Scripps Research Institute | ||||
| Research Priority: Pathogenesis > Cell growth | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Identifying Breast Cancer Targets for Protease Inhibitors | ||||
| Scripps Research Institute | ||||
| Research Priority: Pathogenesis > Outbreak - how cancer spreads | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Studies on the Role of the ER-beta in Breast Cancer | ||||
| Lawrence Berkeley National Laboratory | ||||
| Research Priority: Pathogenesis > Cell growth | ||||
| Award Type: Postdoctoral Fellowship | ||||
| Analysis of a New Human Caspase in Breast Cancer | ||||
| The Burnham Institute for Medical Research | ||||
| Research Priority: Pathogenesis > Searching the unknown | ||||
| Award Type: Postdoctoral Fellowship | ||||
Collaboration Awards: TRC (Translational Research Collaboration) Full Research Awards Top
| Targeted Delivery of an Anti-breast Tumor Agent | ||||
| University of Southern California | ||||
| Research Priority: Innovative Treatments > New drug design | ||||
| Award Type: TRC Full | ||||
| Wnt Signaling in Breast Cancer: Translational Studies | ||||
| University of California, Irvine | ||||
| Research Priority: Innovative Treatments > Gene therapy & other treatments | ||||
| Award Type: TRC Full | ||||
Collaboration Awards: CRC (Community Research Collaboration) Pilot Awards Top
| Does a Peer Navigator Improve Quality of Life at Diagnosis? | ||||
| Stanford University | ||||
| Research Priority: Health Policy & Health Services > Health Policy & Health Services | ||||
| Award Type: CRC Pilot | ||||
Innovative Awards: IDEAS II Top
| Influence of Localized DDT Exposure on Breast Cancer | ||||
| Cedars-Sinai Medical Center | ||||
| Research Priority: Etiology > Environment & gene/environment interactions | ||||
| Award Type: IDEAS II | ||||
| Breast Cancer in California Teachers- Regional Variations | ||||
| Public Health Institute | ||||
| Research Priority: Etiology > Other searches for the causes | ||||
| Award Type: IDEAS II | ||||
| Breast Cancer Prevention by Analogs of EGCG from Green Tea | ||||
| SRI International | ||||
| Research Priority: Innovative Treatments > Immune therapy | ||||
| Award Type: IDEAS II | ||||
| Method for Measuring Breast Epithelial Turnover in Humans | ||||
| University of California, Berkeley | ||||
| Research Priority: Biology of the Normal Breast > Breast function | ||||
| Award Type: IDEAS II | ||||
| Molecular Staging of Breast Cancer Progression | ||||
| University of Southern California | ||||
| Research Priority: Imaging, Biomarkers, & Molecular Pathology > Biomarkers & novel screening | ||||
| Award Type: IDEAS II | ||||
| A Study of the Molecular Heterogeneity of LCIS | ||||
| University of California, Los Angeles | ||||
| Research Priority: Pathogenesis > Unraveling the path to breast cancer | ||||
| Award Type: IDEAS II | ||||
| Cell Growth Control of Breast Epithelial Cells | ||||
| Scripps Research Institute | ||||
| Research Priority: Pathogenesis > Cell growth | ||||
| Award Type: IDEAS II | ||||
| Stress Protein and Drug Resistance in Human Breast Cancer | ||||
| University of Southern California | ||||
| Research Priority: Innovative Treatments > Gene therapy & other treatments | ||||
| Award Type: IDEAS II | ||||
| The Role of IL-8 and its Receptors in Angiogenesis | ||||
| La Jolla Institute for Molecular Medicine | ||||
| Research Priority: Pathogenesis > Outbreak - how cancer spreads | ||||
| Award Type: IDEAS II | ||||
| Metastasis Suppressor Genes for Breast Cancer | ||||
| Stanford University | ||||
| Research Priority: Pathogenesis > Searching the unknown | ||||
| Award Type: IDEAS II | ||||
| Profiling Serine Protease Activities in Breast Cancer | ||||
| Scripps Research Institute | ||||
| Research Priority: Pathogenesis > Outbreak - how cancer spreads | ||||
| Award Type: IDEAS II | ||||
| Immortalization of Human Mammary Epithelial Cells by ZNF217 | ||||
| Lawrence Berkeley National Laboratory | ||||
| Research Priority: Pathogenesis > Unraveling the path to breast cancer | ||||
| Award Type: IDEAS II | ||||
| The Control of Breast Cancer Cell Death | ||||
| Stanford University | ||||
| Research Priority: Pathogenesis > Cell growth | ||||
| Award Type: IDEAS II | ||||
| A Patient Decision Support Framework for Breast Cancer | ||||
| University of California, San Francisco | ||||
| Research Priority: Innovative Treatments > Immune therapy | ||||
| Award Type: IDEAS II | ||||
| Targeted Chemotherapy to Treat Breast Cancer | ||||
| University of California, San Francisco | ||||
| Research Priority: Innovative Treatments > Hormone and chemotherapy targets | ||||
| Award Type: IDEAS II | ||||
| Suppressor Genes of Breast Cancer | ||||
| The Burnham Institute for Medical Research | ||||
| Research Priority: Pathogenesis > Searching the unknown | ||||
| Award Type: IDEAS II | ||||
| DNA Packaging Defects in Breast Cancer | ||||
| Lawrence Berkeley National Laboratory | ||||
| Research Priority: Pathogenesis > Mistakes on the master blueprint | ||||
| Award Type: IDEAS II | ||||
| Cell Adhesion and Drug Resistance in Breast Cancer | ||||
| The Burnham Institute for Medical Research | ||||
| Research Priority: Pathogenesis > Outbreak - how cancer spreads | ||||
| Award Type: IDEAS II | ||||
| Chinese Herbal Therapy (CHT) for Symptom Management | ||||
| University of California, San Francisco | ||||
| Research Priority: Innovative Treatments > Gene therapy & other treatments | ||||
| Award Type: IDEAS II | ||||
| Role of p14ARF in Metastatic Breast Cancer | ||||
| Sidney Kimmel Cancer Center | ||||
| Research Priority: Innovative Treatments > Hormone and chemotherapy targets | ||||
| Award Type: IDEAS II | ||||
| Novel Anti-Angiogenic Agents for Breast Cancer Therapy | ||||
| SRI International | ||||
| Research Priority: Innovative Treatments > New drug design | ||||
| Award Type: IDEAS II | ||||
| Novel Agents for Treatment of Advanced Breast Cancer | ||||
| SRI International | ||||
| Research Priority: Innovative Treatments > Hormone and chemotherapy targets | ||||
| Award Type: IDEAS II | ||||
| Thrombosis for Anti-angiogenic Therapy of Breast Cancer | ||||
| University of California, Irvine | ||||
| Research Priority: Innovative Treatments > Gene therapy & other treatments | ||||
| Award Type: IDEAS II | ||||
| A Vascular Restriction of Mammary Tumor Progression | ||||
| The Burnham Institute for Medical Research | ||||
| Research Priority: Biology of the Normal Breast > Breast function | ||||
| Award Type: IDEAS II | ||||
| Pregnancy and Breast Cancer: an Immunological Connection? | ||||
| University of California, San Francisco | ||||
| Research Priority: Biology of the Normal Breast > Breast function | ||||
| Award Type: IDEAS II | ||||
| Role of p53 in Irradiated Stroma and Mammary Carcinogenesis | ||||
| Lawrence Berkeley National Laboratory | ||||
| Research Priority: Pathogenesis > Unraveling the path to breast cancer | ||||
| Award Type: IDEAS II | ||||
Topic-targeted Research Awards: RFA (Request for Applications) Top
| Genetic and Environmental Modifiers of Breast Cancer Risk | ||||
| University of California, Irvine | ||||
| Research Priority: Prevention & Risk Reduction > Active lifestyle modification | ||||
| Award Type: RFA | ||||
| Bovine Leukemia Virus Infection and Human Breast Cancer Risk | ||||
| University of California, Berkeley | ||||
| Research Priority: Prevention & Risk Reduction > Other searches for the causes | ||||
| Award Type: RFA | ||||
| Upregulation of BRCA1 as a Cancer Preventive Strategy | ||||
| University of Southern California | ||||
| Research Priority: Prevention & Risk Reduction > Other searches for the causes | ||||
| Award Type: RFA | ||||
| Genetic Changes in Normal Epithelium of the Cancerous Breast | ||||
| California Pacific Medical Center Research Institute | ||||
| Research Priority: Biology of the Normal Breast > Defining the danger | ||||
| Award Type: RFA | ||||
| Mammographic Density, HRT and Hormonal Activity Genes | ||||
| University of Southern California | ||||
| Research Priority: Prevention & Risk Reduction > Active lifestyle modification | ||||
| Award Type: RFA | ||||
| Mechanisms of Reduced Metastasis by Conjugated Linoleic Acid | ||||
| University of California, Davis | ||||
| Research Priority: Prevention & Risk Reduction > Other searches for the causes | ||||
| Award Type: RFA | ||||
Career Development Awards: New Investigator Top
| TGF-B3 and small GTPases in Invasive Breast Cancer | ||||
| Childrens Hospital, Los Angeles | ||||
| Research Priority: Pathogenesis > Outbreak - how cancer spreads | ||||
| Award Type: New Investigator | ||||
| Analysis of Genes Predictive of Breast Cancer Metastasis | ||||
| University of California, Davis | ||||
| Research Priority: Pathogenesis > Outbreak - how cancer spreads | ||||
| Award Type: New Investigator | ||||
| Cell-Based Immunotherapy for Breast Cancer | ||||
| University of California, San Francisco | ||||
| Research Priority: Innovative Treatments > Immune therapy | ||||
| Award Type: New Investigator | ||||
| Novel Mechanisms of ErbB-2-Mediated Breast Cancer Metastasis | ||||
| Scripps Research Institute | ||||
| Research Priority: Pathogenesis > Cell growth | ||||
| Award Type: New Investigator | ||||
| Tumor Suppression by Dystrogylcan in Breast Epithelial Cells | ||||
| Lawrence Berkeley National Laboratory | ||||
| Research Priority: Pathogenesis > Outbreak - how cancer spreads | ||||
| Award Type: New Investigator | ||||
| Profiling of Tyrosine Phosphatases in Breast Cancer | ||||
| University of California, Davis | ||||
| Research Priority: Etiology > Environment & gene/environment interactions | ||||
| Award Type: New Investigator | ||||
